Seres Therapeutics Inc (MCRB)

HEALTH CARE: PHARMACEUTICALS
SIC: PHARMACEUTICAL PREPARATIONS

200 SIDNEY STREET CAMBRIDGE, MA 02139

Seres Therapeutics, Inc. operates as a microbiome therapeutics platform company. The Company focuses on developing biological drugs, which are designed to restore health by repairing the function of a dysbiotic microbiome. Seres Therapeutics also conducts research on metabolic diseases.

Data as of 2021-02-20 14:03:42 -0500
Market Cap2.231 Billion Shares Outstanding91.248 Million Avg 30-day Volume850.138 Thousand
P/E Ratio-24.88505 Dividend Yield0.0 EPS-1.2
Price/Sales101.7 Debt to Equity1.89 EBITDA-82.454 Million
Price to Book Value12.59 Forward PE-40.59 Enterprise Value2.094 Billion
Total Cash297.914 Million Current Debt45.77 Million Gross Profit23.273 Million
BETA0.0 52-week High/Low38.5 / 2.52 Price to Cash FLow (P/CF) -9999999.0
Data provided by IEX Cloud
View SEC Filings from MCRB instead.
Q4 2020 All 13F Filers Prior Change Hedge Funds 1 Prior Change
In top 10: 2 3 -33.33% 0 (0.0%) 1 (0.06%) -100.0%
Funds Holding: 144 113 27.43% 43 (2.59%) 38 (2.37%) 13.16%
13F shares: 86.513 Million 86.062 Million 0.52% 24.095 Million 26.284 Million -8.33%
% Ownership 94.8104 94.3161 0.52% 26.4057 28.8047 -8.33%
New Positions: 50 37 35.14% 17 18 -5.56%
Increased Positions 47 39 20.51% 13 5 160.0%
Closed Positions 17 17 0.0% 12 3 300.0%
Reduced Positions 35 30 16.67% 9 15 -40.0%
Total Calls 683.591 Thousand 3.006 Million -77.26% 341.454 Thousand 1.368 Million -75.05%
Total Puts 272.538 Thousand 646.706 Thousand -57.86% 46.8 Thousand 377.6 Thousand -87.61%
PUT/CALL Ratio 0.4 0.22 81.82% 0.14 0.28 -50.0%
1 hedge funds and active managers as identified by whalewisdom.com through public filings.

View recent insider trading info

Funds Holding MCRB (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding MCRB BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

none

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

SHAFF ERIC D. PRESIDENT, CEO

  • Officer
  • Director
0 2021-02-04 1

DESROSIER THOMAS CHIEF LEGAL OFFICER AND EVP

  • Officer
0 2021-02-04 1

HENN MATTHEW R. SEE REMARKS

  • Officer
0 2021-02-04 2

CHAPMAN MARCUS SEE REMARKS

  • Officer
0 2021-02-04 2

VON MOLTKE LISA SEE REMARKS

  • Officer
0 2021-02-04 3

YOUNG TERESA L. SEE REMARKS

  • Officer
0 2021-02-04 3

BERENSON STEPHEN

  • Director
3,589 2020-11-23 2

FLAGSHIP VENTURES FUND IV GENERAL PARTNER LLC

FLAGSHIP VENTURES FUND IV, L.P.

FLAGSHIP VENTURES FUND IV-RX, L.P.

NUTRITIONAL HEALTH LTP FUND GENERAL PARTNER LLC

NUTRITIONAL HEALTH LTP FUND, L.P.

FLAGSHIP PIONEERING INC.

FLAGSHIP PIONEERING FUND VI GENERAL PARTNER LLC

FLAGSHIP PIONEERING FUND VI, L.P.

AFEYAN NOUBAR

  • 10% Owner
15,049,991 2020-11-23 1

EGE DAVID S. SEE REMARKS

  • Officer
0 2020-10-19 2

KENDER RICHARD N

  • Director
0 2020-06-18 1

AUSIELLO DENNIS A

  • Director
0 2020-06-18 1

BEHAR GREGORY

  • Director
0 2020-06-18 1

GRAVES KURT

  • Director
0 2020-06-18 1

DERE WILLARD H

  • Director
0 2020-06-18 1

ZAUSNER MERYL

  • Director
0 2020-06-18 1

BIONDI PAUL

  • Director
0 2020-06-18 3

AUNINS JOHN G. CHIEF TECHNOLOGY OFFICER & EVP

  • Officer
0 2020-01-29 0

AFEYAN NOUBAR

  • Director
  • 10% Owner
21,586,905 2019-06-18 0

FLAGSHIP PIONEERING INC.

FLAGSHIP PIONEERING FUND VI GENERAL PARTNER LLC

FLAGSHIP PIONEERING FUND VI, L.P.

NUTRITIONAL HEALTH LTP FUND GENERAL PARTNER LLC

NUTRITIONAL HEALTH LTP FUND, L.P.

  • 10% Owner
4,444,444 2019-06-18 0

KIM LORENCE H.

  • Director
0 2019-06-13 0

POMERANTZ ROGER

  • Director
0 2019-06-13 0

COOK DAVID N SEE REMARKS

  • Officer
147,435 2019-01-26 0

HORGAN KEVIN CHIEF MEDICAL OFFICER AND EVP

  • Officer
0 2019-01-25 0

TRUCKSIS MICHELE SEE REMARKS

  • Officer
4,893 2018-01-26 0

HASHAD WAEL EVP & CHIEF COMMERCIAL OFFICER

  • Officer
0 2017-01-26 0

HUTT PETER BARTON

  • Director
0 2016-06-15 0

AFEYAN NOUBAR

FLAGSHIP VENTURES FUND 2007, L.P.

FLAGSHIP VENTURES FUND IV, L.P.

FLAGSHIP VENTURES FUND IV-RX, L.P.

FLAGSHIP VENTURELABS IV, LLC

FLAGSHIP VENTURES 2007 GENERAL PARTNER LLC

FLAGSHIP VENTURES FUND IV GENERAL PARTNER LLC

KANIA EDWIN M JR

  • Director
  • 10% Owner
14,641,852 2016-05-25 0

NESTLE HEALTH SCIENCE US HOLDINGS, INC.

NESTLE SA

NIMCO US, INC.

  • 10% Owner
6,888,888 2015-07-01 0

CAUTREELS WERNER

  • Director
0 2015-06-25 0

AFEYAN NOUBAR

FLAGSHIP VENTURES FUND 2007, L.P.

FLAGSHIP VENTURES FUND IV, L.P.

FLAGSHIP VENTURES FUND IV-RX, L.P.

FLAGSHIP VENTURES 2007 GENERAL PARTNER LLC

FLAGSHIP VENTURES FUND IV GENERAL PARTNER LLC

KANIA EDWIN M JR

  • Director
  • 10% Owner
14,682,876 2015-06-25 0

Insider Transactions Last 60 Days

Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
Disposed
Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days

HENN MATTHEW R. - Officer SEE REMARKS

2021-02-08 18:47:36 -0500 2021-02-04 A 130,000 a 130,000 direct

CHAPMAN MARCUS - Officer SEE REMARKS

2021-02-08 18:55:02 -0500 2021-02-04 A 24,000 a 24,000 direct

YOUNG TERESA L. - Officer SEE REMARKS

2021-02-08 18:51:38 -0500 2021-02-04 A 90,000 a 90,000 direct

CHAPMAN MARCUS - Officer SEE REMARKS

2021-02-08 18:55:02 -0500 2021-02-04 A 12,000 a 12,000 direct

SHAFF ERIC D. - Director - Officer PRESIDENT, CEO

2021-02-08 18:50:15 -0500 2021-02-04 A 350,000 a 350,000 direct

DESROSIER THOMAS - Officer CHIEF LEGAL OFFICER AND EVP

2021-02-08 18:55:18 -0500 2021-02-04 A 100,000 a 100,000 direct

VON MOLTKE LISA - Officer SEE REMARKS

2021-02-08 18:53:16 -0500 2021-02-04 A 110,000 a 110,000 direct

* -

Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

IBR Securities Loan Availability

Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

Security Date/Time Rebate Rate Fee Rate Shares Available
SERES THERAPEUTICS INC MCRB 2021-03-01 19:15:03 UTC -0.2722 0.3422 900000
SERES THERAPEUTICS INC MCRB 2021-03-01 18:45:03 UTC -0.273 0.343 900000
SERES THERAPEUTICS INC MCRB 2021-03-01 18:15:03 UTC -0.273 0.343 900000
SERES THERAPEUTICS INC MCRB 2021-03-01 17:45:03 UTC -0.273 0.343 900000
SERES THERAPEUTICS INC MCRB 2021-03-01 17:15:03 UTC -0.273 0.343 900000
SERES THERAPEUTICS INC MCRB 2021-03-01 16:45:03 UTC -0.2708 0.3408 900000
SERES THERAPEUTICS INC MCRB 2021-03-01 16:15:02 UTC -0.2708 0.3408 900000
SERES THERAPEUTICS INC MCRB 2021-03-01 15:45:03 UTC -0.2708 0.3408 900000
SERES THERAPEUTICS INC MCRB 2021-03-01 15:15:02 UTC -0.2708 0.3408 900000
SERES THERAPEUTICS INC MCRB 2021-03-01 14:45:03 UTC -0.1861 0.2561 900000
SERES THERAPEUTICS INC MCRB 2021-03-01 14:15:03 UTC -0.1861 0.2561 900000
SERES THERAPEUTICS INC MCRB 2021-03-01 13:45:03 UTC -0.1861 0.2561 900000
SERES THERAPEUTICS INC MCRB 2021-03-01 13:15:03 UTC -0.1861 0.2561 900000
SERES THERAPEUTICS INC MCRB 2021-03-01 12:45:03 UTC -0.1861 0.2561 900000
SERES THERAPEUTICS INC MCRB 2021-02-26 18:45:03 UTC -0.183 0.253 1000000
SERES THERAPEUTICS INC MCRB 2021-02-26 18:15:02 UTC -0.183 0.253 1000000
SERES THERAPEUTICS INC MCRB 2021-02-26 17:45:02 UTC -0.183 0.253 1000000
SERES THERAPEUTICS INC MCRB 2021-02-26 17:15:03 UTC -0.183 0.253 1000000
SERES THERAPEUTICS INC MCRB 2021-02-26 16:45:03 UTC -0.183 0.253 1000000
SERES THERAPEUTICS INC MCRB 2021-02-26 16:15:02 UTC -0.183 0.253 1000000

Current Active Short Positions

Holder Issuer Net Short Position Position Date Origin
RUSSELL INVESTMENT CO- U.S. Dynamic Equity Fund MCRB -3032.0 shares, $-84562.48 2020-10-31 N-PORT
RUSSELL INVESTMENT CO- U.S. Small Cap Equity Fund MCRB -14497.0 shares, $-404321.33 2020-10-31 N-PORT
RUSSELL INVESTMENT CO- Sustainable Equity Fund MCRB -2848.0 shares, $-79430.72 2020-10-31 N-PORT
RUSSELL INVESTMENT FUNDS- U.S. Small Cap Equity Fund MCRB -2063.0 shares, $-50543.5 2020-12-31 N-PORT

Elevate your investments